Insulin-like growth factor I and interleukin-6 contribute synergistically to disability and mortality in older women

Journal of Clinical Endocrinology and Metabolism

Volumn 88, Issue 5, 2003, Pages 2019-2025

  Cappola, Anne R ^a,f   Xue, Qian Li ^b   Ferrucci, Luigi ^c   Guralnik, Jack M ^d   Volpato, Stefano ^e   Fried, Linda P ^b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b DEPARTMENT OF PATHOLOGY   (United States)

^c INRCA   (Italy)

^d NATIONAL INSTITUTE ON AGING   (United States)

^e UNIVERSITY OF FERRARA   (Italy)

^f UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6; SOMATOMEDIN C;

AGE; AGED; ARTICLE; COHORT ANALYSIS; DAILY LIFE ACTIVITY; DEATH; FEMALE; FOLLOW UP; GERIATRIC DISORDER; HIGH RISK POPULATION; HUMAN; HUMAN EXPERIMENT; INCIDENCE; INSTRUMENTATION; MOBILIZATION; MORTALITY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RISK ASSESSMENT; RISK FACTOR; STATISTICAL SIGNIFICANCE; TASK PERFORMANCE; WALKING SPEED;

ACTIVITIES OF DAILY LIVING; AGED; AGING; COHORT STUDIES; DISABLED PERSONS; DRUG SYNERGISM; ENDOCRINE GLANDS; FEMALE; HUMANS; IMMUNITY; INSULIN-LIKE GROWTH FACTOR I; INTERLEUKIN-6; MORTALITY; RISK FACTORS; WALKING;

EID: 0038369150     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2002-021694     Document Type: Article

References (42)

1. Populations Projections Program PDUSCB Projections of the total resident population by 5-year age groups, race, and Hispanic origin with special age categories: middle series, 1999 to 2100 (available from URL: http://www. census.gov/population/www/projections/natsum.html)
2. Administration on Aging USDoHaHS A profile of older Americans: 2001 (available from URL: http://www.aoa.gov/aoa/stats/profile/2002/12.html)
3. Landin-Wilhelmsen K, Wilhelmsen L, Lappas G, Rosen T, Lindstedt G, Lundberg PA, Bengtsson BA 1994 Serum insulin-like growth factor I in a random population sample of men and women: relation to age, sex, smoking habits, coffee consumption and physical activity, blood pressure and concentrations of plasma lipids, fibrinogen, parathyroid hormone and osteocalcin. Clin Endocrinol (Oxf) 41:351-357
4. Papadakis MA, Grady D, Tiemey MJ, Black D, Wells L, Grunfeld C 1995 Insulin-like growth factor 1 and functional status in healthy older men. J Am Geriatr Soc 43:1350-1355
5. Goodman-Gruen D, Barrett-Connor E 1997 Epidemiology of insulin-like growth factor-I in elderly men and women. The Rancho Bernardo Study. Am J Epidemiol 145:970-976
6. Harris TB, Kiel D, Roubenoff R, Langlois J, Hannan M, Havlik R, Wilson P 1997 Association of insulin-like growth factor-I with body composition, weight history, and past health behaviors in the very old: the Framingham Heart Study. J Am Geriatr Soc 45:133-139
7. O'Connor KG, Tobin JD, Harman SM, Plato CC, Roy TA, Sherman SS, Blackman MR 1998 Serum levels of insulin-like growth factor-I are related to age and not to body composition in healthy women and men. J Gerontol A Biol Sci Med Sci 53:M176-M182
8. Boonen S, Lysens R, Verbeke G, Joosten E, Dejaeger E, Pelemans W, Flamaing J, Bouillon R 1998 Relationship between age-associated endocrine deficiencies and muscle function in elderly women: a cross-sectional study. Age Ageing 27:449-454
9. Rosen CJ 2000 Growth hormone and aging. Endocrine 12:197-201
10. Cappola AR, Bandeen-Roche K, Wand GS, Volpato S, Fried LP 2001 Association of IGF-I levels with muscle strength and mobility in older women. J Clin Endocrinol Metab 86:4139-4146
11. Kiel DP, Puhl J, Rosen CJ, Berg K, Murphy JB, MacLean DB 1998 Lack of an association between insulin-like growth factor-I and body composition, muscle strength, physical performance or self-reported mobility among older persons with functional limitations. J Am Geriatr Soc 46:822-828
12. Janssen JA, Stolk RP, Pols HA, Grobbee DE, Lamberts SW 1998 Serum free and total insulin-like growth factor-I, insulin-like growth factor binding protein-1 and insulin-like growth factor binding protein-3 levels in healthy elderly individuals. Relation to self-reported quality of health and disability. Gerontology 44:277-280
13. Ershler WB, Keller ET 2000 Age-associated increased interleukin-6 gene expression, late-life diseases, and frailty. Annu Rev Med 51:245-270
14. Cohen HJ, Pieper CF, Harris T, Rao KM, Currie MS 1997 The association of plasma IL-6 levels with functional disability in community-dwelling elderly. J Gerontol A Biol Sci Med Sci 52:M201-M208
15. Ferrucci L, Harris TB, Guralnik JM, Tracy RP, Corti MC, Cohen HJ, Penninx B, Pahor M, Wallace R, Havlik RJ 1999 Serum IL-6 level and the development of disability in older persons. J Am Geriatr Soc 47:639-646
16. Harris TB, Ferrucci L, Tracy RP, Corti MC, Wacholder S, Ettinger Jr WH, Heimovitz H, Cohen HJ, Wallace R 1999 Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly. Am J Med 106:506-512
17. Volpato S, Guralnik JM, Ferrucci L, Balfour J, Chaves P, Fried LP, Harris TB 2001 Cardiovascular disease, interleukin-6, and risk of mortality in older women: the women's health and aging study. Circulation 103:947-953
18. Bruunsgaard H, Pedersen M, Pedersen BK 2001 Aging and proinflammatory cytokines. Curr Opin Hematol 8:131-136
19. De Benedetti F, Alonzi T, Moretta A, Lazzaro D, Costa P, Poll V, Martini A, Ciliberto G, Fattori E 1997 Interleukin 6 causes growth impairment in transgenic mice through a decrease in insulin-like growth factor-I. A model for stunted growth in children with chronic inflammation. J Clin Invest 99:643-650
20. Sesmilo G, Biller BM, Llevadot J, Hayden D, Hanson G, Rifai N, Klibanski A 2000 Effects of growth hormone administration on inflammatory and other cardiovascular risk markers in men with growth hormone deficiency. A randomized, controlled clinical trial. Ann Intern Med 133:111-122
21. Serri O, St Jacques P, Sartippour M, Renier G 1999 Alterations of monocyte function in patients with growth hormone (GH) deficiency: effect of substitutive GH therapy. J Clin Endocrinol Metab 84:58-63
22. Kasper JD, Shapiro S, Guralnik JM, Bandeen-Roche KJ, Fried LP 1999 Designing a community study of moderately to severely disabled older women: the Women's Health and Aging Study. Ann Epidemiol 9:498-507
23. Guralnik JM, Fried LP, Simonsick EL, Kasper JD, Lafferty ME, eds. 1995 The Women's Health and Aging Study: health and social characteristics of older women with disability. Bethesda: NIA; NIH Publication 95-4009 (available from: URL: http://www.nia.nih.gov/health/pubs/whasbook/title.htm)
24. Tinetti ME, Inouye SK, Gill TM, Doucette JT 1995 Shared risk factors for falls, incontinence, and functional dependence. Uniting the approach to geriatric syndromes. JAMA 273:1348-1353
25. Rantanen T, Guralnik JM, Ferrucci L, Penninx BW, Leveille S, Sipila S, Fried LP 2001 Coimpairments as predictors of severe walking disability in older women. J Am Geriatr Soc 49:21-27
26. Stiratelli R, Laird N, Ware JH 1984 Random-effects models for serial observations with binary response. Biometrics 40:961-971
27. Prentice RL, Gloeckler LA 1978 Regression analysis of grouped survival data with application to breast cancer data. Biometrics 34:57-67
28. Hedeker D 2001 MIXNO: a computer program for mixed-effects nominal logistic regression. (available from: URL: http://www.uic.edu/~hedeker/mix.html)
29. Arvat E, Broglio F, Ghigo E 2000 Insulin-like growth factor I: implications in aging. Drugs Aging 16:29-40
30. Papanicolaou DA, Wilder RL, Manolagas SC, Chrousos GP 1998 The pathophysiologic roles of interleukin-6 in human disease. Ann Intern Med 128:127-137
31. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM 2001 C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 286:327-334
32. Libby P, Ridker PM, Maseri A 2002 Inflammation and atherosclerosis. Circulation 105:1135-1143 De
33. De Benedetti F, Pignatti P, Vivarelli M, Meazza C, Ciliberto G, Savino R, Martini A 2001 In vivo neutralization of human IL-6 (hIL-6) achieved by immunization of hIL-6-transgenic mice with a hIL-6 receptor antagonist. J Immunol 166:4334-4340
34. Lelbach A, Scharf JG, Ramadori G 2001 Regulation of insulin-like growth factor-I and of insulin-like growth factor binding protein-1, -3 and -4 in cocultures of rat hepatocytes and Kupffer cells by mterleukin-6. J Hepatol 35: 558-567
35. De Benedetti F, Meazza C, Oliveri M, Pignatti P, Vivarelli M, Alonzi T, Fattori E, Garrone S, Barreca A, Martini A 2001 Effect of IL-6 on IGF binding protein-3: a study in IL-6 transgenic mice and in patients with systemic juvenile idiopathic arthritis. Endocrinology 142:4818-4826
36. Sesmilo G, Miller KK, Hayden D, Klibanski A 2001 Inflammatory cardio-vascular risk markers in women with hypopituitarism. J Clin Endocrinol Metab 86:5774-5781
37. Moutoussamy S, Kelly PA, Finidori J 1998 Growth-hormone-receptor and cytokine-receptor-family signaling. Eur J Biochem 255:1-11
38. Bermon S, Ferrari P, Bernard P, Altare S, Dolisi C 1999 Responses of total and free insulin-like growth factor-I and insulin-like growth factor binding protein-3 after resistance exercise and training in elderly subjects. Acta Physiol Scand 165:51-56
39. Poehlman ET, Rosen CJ, Copeland KC 1994 The influence of endurance training on insulin-like growth factor-1 in older individuals. Metabolism 43: 1401-1405
40. Sullivan DH, Carter WJ 1994 Insulin-like growth factor I as an indicator of protein-energy undernutrition among metabolically stable hospitalized elderly. J Am Coll Nutr 13:184-191
41. Janssen JA, Stolk RP, Pols HA, Grobbee DE, de Jong FH, Lamberts SW 1998 Serum free IGF-I, total IGF-I, IGFBP-1 and IGFBP-3 levels in an elderly population: relation to age and sex steroid levels. Clin Endocrinol (Oxf) 48:471-478
42. Juul A, Main K, Blum WF, Lindholm J, Ranke MB, Skakkebaek NE 1994 The ratio between serum levels of insulin-like growth factor (IGF)-I and the IGF bindmg proteins (IGFBP-1, 2 and 3) decreases with age in healthy adults and plasma IL-6 levels with functional disability in community-dwelling elderly. J Gerontol A Biol Sci Med Sci 52:M201-M208